Discovery of drug candidate to potentially tackle ER-positive breast cancer

by

An international team of researchers, led by Pfizer in collaboration with Monash University and the Australian-based Cancer Therapeutics Cooperative Research Center, have discovered a pre-clinical drug candidate demonstrating anti-tumor activity in Estrogen Receptor (ER) positive breast cancer models.

Leave A Comment

Your email address will not be published. Required fields are marked *